Longmoney -
I agree that Titan is setting up for an M&A. The recent evidence is as follows:
1. Released video of a working product
2. Released a PR stating that they have completed animal tissue testing and performed a successful chole
3. Sherry Betner's contract includes an M&A clause
4. Their business development guy is out with no immediate plans to replace him.
5. They seem to be tighten up their IP portfolio a bit (see revised patent published Tuesday)
Taken all together, this smells to me like they might be moving toward an M&A strategy. IMHO, they would not have been able to cash up or complete tissue testing is something was going horribly awry behind the scenes.
My wild a**ed guess is that they will plow through the tissue validation studies over the summer and get into the home stretch of the FDA approval process, at which point the M&A will happen.